Adverse Effects of Carbetocin versus Oxytocin in the Prevention of Postpartum Haemorrhage after Caesarean Section: A Randomized Controlled Trial
Purpose. To compare the incidence of nausea, vomiting, and arterial hypotension between carbetocin and oxytocin to prevent haemorrhage after caesarean section (CS). Methods. A randomized controlled trial in term pregnant women undergoing planned CS. Groups were randomized to carbetocin or oxytocin....
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Journal of Pregnancy |
| Online Access: | http://dx.doi.org/10.1155/2018/1374150 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832561986650505216 |
|---|---|
| author | D. Mannaerts L. Van der Veeken H. Coppejans Y. Jacquemyn |
| author_facet | D. Mannaerts L. Van der Veeken H. Coppejans Y. Jacquemyn |
| author_sort | D. Mannaerts |
| collection | DOAJ |
| description | Purpose. To compare the incidence of nausea, vomiting, and arterial hypotension between carbetocin and oxytocin to prevent haemorrhage after caesarean section (CS). Methods. A randomized controlled trial in term pregnant women undergoing planned CS. Groups were randomized to carbetocin or oxytocin. Blood pressure (BP), heart rate, presence of nausea/vomitus, and need for vasopressors were evaluated throughout surgery. Preoperative and postoperative haemoglobin and haematocrit levels were compared. Results. Fifty-eight women were randomized (carbetocin n=32; oxytocin n=26). Both medications had hypotensive effect, difference in BP for carbetocin versus oxytocin: systolic (14.4 ± 2.4 mmHg versus 8.5 ± 1.8 mmHg); diastolic (7.8 ± 1.6 mmHg versus 8.9 ± 3.0 mmHg) without significant difference between the drugs (p=0.1 and p=0.7). Both groups had similar needs for vasopressors. The presence of nausea was not rare, but the difference was not statistically significant (p=0.4). Average blood loss was slightly lower in the carbetocin group but not statistically significant (p=0.8). Conclusion. In planned CS, a possible clinical significant lower incidence of nausea after carbetocin was noted but this was not statistically significant. There were no differences regarding BP, heart rate, the need for vasopressor, and blood loss. The study was registered in the International Journal of Clinical Trials (ISRCTN 95504420, 2/2017). |
| format | Article |
| id | doaj-art-84a0540205c242b4995b745c3354a486 |
| institution | Kabale University |
| issn | 2090-2727 2090-2735 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Pregnancy |
| spelling | doaj-art-84a0540205c242b4995b745c3354a4862025-02-03T01:23:46ZengWileyJournal of Pregnancy2090-27272090-27352018-01-01201810.1155/2018/13741501374150Adverse Effects of Carbetocin versus Oxytocin in the Prevention of Postpartum Haemorrhage after Caesarean Section: A Randomized Controlled TrialD. Mannaerts0L. Van der Veeken1H. Coppejans2Y. Jacquemyn3Department of Obstetrics and Gynaecology, Antwerp University Hospital (UZA), Edegem, BelgiumDepartment of Obstetrics and Gynaecology, Antwerp University Hospital (UZA), Edegem, BelgiumDepartment of Anaesthesiology, Antwerp University Hospital (UZA), Edegem, BelgiumDepartment of Obstetrics and Gynaecology, Antwerp University Hospital (UZA), Edegem, BelgiumPurpose. To compare the incidence of nausea, vomiting, and arterial hypotension between carbetocin and oxytocin to prevent haemorrhage after caesarean section (CS). Methods. A randomized controlled trial in term pregnant women undergoing planned CS. Groups were randomized to carbetocin or oxytocin. Blood pressure (BP), heart rate, presence of nausea/vomitus, and need for vasopressors were evaluated throughout surgery. Preoperative and postoperative haemoglobin and haematocrit levels were compared. Results. Fifty-eight women were randomized (carbetocin n=32; oxytocin n=26). Both medications had hypotensive effect, difference in BP for carbetocin versus oxytocin: systolic (14.4 ± 2.4 mmHg versus 8.5 ± 1.8 mmHg); diastolic (7.8 ± 1.6 mmHg versus 8.9 ± 3.0 mmHg) without significant difference between the drugs (p=0.1 and p=0.7). Both groups had similar needs for vasopressors. The presence of nausea was not rare, but the difference was not statistically significant (p=0.4). Average blood loss was slightly lower in the carbetocin group but not statistically significant (p=0.8). Conclusion. In planned CS, a possible clinical significant lower incidence of nausea after carbetocin was noted but this was not statistically significant. There were no differences regarding BP, heart rate, the need for vasopressor, and blood loss. The study was registered in the International Journal of Clinical Trials (ISRCTN 95504420, 2/2017).http://dx.doi.org/10.1155/2018/1374150 |
| spellingShingle | D. Mannaerts L. Van der Veeken H. Coppejans Y. Jacquemyn Adverse Effects of Carbetocin versus Oxytocin in the Prevention of Postpartum Haemorrhage after Caesarean Section: A Randomized Controlled Trial Journal of Pregnancy |
| title | Adverse Effects of Carbetocin versus Oxytocin in the Prevention of Postpartum Haemorrhage after Caesarean Section: A Randomized Controlled Trial |
| title_full | Adverse Effects of Carbetocin versus Oxytocin in the Prevention of Postpartum Haemorrhage after Caesarean Section: A Randomized Controlled Trial |
| title_fullStr | Adverse Effects of Carbetocin versus Oxytocin in the Prevention of Postpartum Haemorrhage after Caesarean Section: A Randomized Controlled Trial |
| title_full_unstemmed | Adverse Effects of Carbetocin versus Oxytocin in the Prevention of Postpartum Haemorrhage after Caesarean Section: A Randomized Controlled Trial |
| title_short | Adverse Effects of Carbetocin versus Oxytocin in the Prevention of Postpartum Haemorrhage after Caesarean Section: A Randomized Controlled Trial |
| title_sort | adverse effects of carbetocin versus oxytocin in the prevention of postpartum haemorrhage after caesarean section a randomized controlled trial |
| url | http://dx.doi.org/10.1155/2018/1374150 |
| work_keys_str_mv | AT dmannaerts adverseeffectsofcarbetocinversusoxytocininthepreventionofpostpartumhaemorrhageaftercaesareansectionarandomizedcontrolledtrial AT lvanderveeken adverseeffectsofcarbetocinversusoxytocininthepreventionofpostpartumhaemorrhageaftercaesareansectionarandomizedcontrolledtrial AT hcoppejans adverseeffectsofcarbetocinversusoxytocininthepreventionofpostpartumhaemorrhageaftercaesareansectionarandomizedcontrolledtrial AT yjacquemyn adverseeffectsofcarbetocinversusoxytocininthepreventionofpostpartumhaemorrhageaftercaesareansectionarandomizedcontrolledtrial |